$RKLB

Why Rocket Lab Stock Is Sinking After Hours — and What Wall Street Sees Next

Rocket Lab's shares fell 8% in after-hours trading after delaying the Neutron rocket's debut to 2027 due to manufacturing issues. Neutron is key to the company's growth plans. Despite this, Rocket Lab reported record Q2 revenue of $234M, up 62% YoY, and a $2.36B backlog. Analysts maintain a Strong Buy rating with an average price target of $104.44.

Original reporting
Published Oct 14, 2026, 9:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 9:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$RKLB
Bearish
high confidence
Mentioned
$RKLB
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$RKLBBearishMed
01

Why it matters

The delay directly caused an 8% after‑hours price drop, indicating immediate market reaction.

02

Market read

The news is material for traders focused on aerospace and satellite launch equities, prompting short‑term downside risk.

03

What to watch

The $397 M Space Force contract and the pending Iridium acquisition could provide long‑term upside despite the short‑term setback.

Relevance 7/10Novelty 8/10Timing: after‑hours today

Background

Rocket Lab reported record Q2 revenue and a growing backlog, but the Neutron launch delay introduces near‑term execution risk.

Company-level read

Ticker impact

$RKLBBearishHigh confidence
Context

Rocket Lab shares fell 8% in after‑hours trading after the company announced a delay of the Neutron rocket launch to 2027 due to a carbon‑composite tank issue.

Expected impact

downward pressure as investors price in the launch delay and reduced near‑term revenue visibility

Evidence & confidence

The news is the first report of a material schedule slip for a flagship product, triggered an 8% after‑hours sell‑off, and affects future contract revenue.

Market effects

Potential slowdown for the small‑sat launch market as competitors may capture contracts while Rocket Lab resolves the Neutron issue.

U.S. space‑tech investors may reassess exposure to launch‑service providers.

Limited; impact confined to Rocket Lab and its immediate supply chain.

Counterpoint

If the delay is isolated and the backlog of contracts remains solid, the stock could rebound on the strength of its record Q2 revenue and backlog.

Key entities

  • Rocket Lab

    U.S. space launch services provider (NASDAQ:RKLB).

  • Neutron rocket

    Rocket Lab's upcoming heavy‑lift launch vehicle.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.

$RKLBMed

RKLB Stock Climbs Overnight: Rocket Lab Targets 12 Hypersonic Tests As US Pushes For Faster Weapons Development

Rocket Lab (RKLB) shares rose 1% overnight after announcing 12 hypersonic test launches this year, supporting U.S. weapons development. The company's HASTE vehicle offers low-cost, high-frequency testing. RKLB stock fell 2% to $64.22 on Tuesday, down 8% year-to-date. Recent contracts include a $190M deal for 20 flights and a $266M Space Force contract.